Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer.

Details

Language :

English

ISSN :

01676997

Volume :

29

Issue :

2

Database :

Complementary Index

Journal :

Investigational New Drugs

Publication Type :

Academic Journal

Accession number :

58002784

Full Text :

https://doi.org/10.1007/s10637-009-9337-2